Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Millar

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
New Directions for Youth Development|May 26, 2007
The Scottish perspective: a pathway to progress?Jeremy Millar
Nurse Education Today|November 1, 2011
Involving service users in the classroom with social work studentsRob Mackay, Jeremy Millar
Brachytherapy|January 27, 2023
Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancerWee Loon Ong, Jeremy Millar
Journal of Medical Imaging and Radiation Oncology|March 4, 2022
'With great power comes great responsibility': An impetus for quality and safety in radiation oncologyMadhavi Chilkuri, Jeremy Millar, Gerard Adams
Brachytherapy|December 27, 2016
Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institutionWee Loon Ong, Bronwyn Matheson, Jeremy Millar
BMJ Open|August 22, 2019
Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) modelsArul Earnest, Sue M Evans, Fanny Sampurno, et al.
BJU International|July 28, 2017
Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancerWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
BJU International|August 29, 2015
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centreWee Loon Ong, Paul Manohar, Jeremy Millar, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in AustraliaWee Loon Ong, Melanie Evans, Nathan Papa, et al.
Journal of Medical Imaging and Radiation Oncology|October 9, 2018
Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry VictoriaWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
New Directions for Youth Development|May 26, 2007
The Scottish perspective: a pathway to progress?Jeremy Millar
Nurse Education Today|November 1, 2011
Involving service users in the classroom with social work studentsRob Mackay, Jeremy Millar
Brachytherapy|January 27, 2023
Late, persistent, substantial treatment-related symptoms (LAPERS) following low-dose-rate brachytherapy for prostate cancerWee Loon Ong, Jeremy Millar
Journal of Medical Imaging and Radiation Oncology|March 4, 2022
'With great power comes great responsibility': An impetus for quality and safety in radiation oncologyMadhavi Chilkuri, Jeremy Millar, Gerard Adams
Brachytherapy|December 27, 2016
Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institutionWee Loon Ong, Bronwyn Matheson, Jeremy Millar
BMJ Open|August 22, 2019
Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) modelsArul Earnest, Sue M Evans, Fanny Sampurno, et al.
BJU International|July 28, 2017
Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancerWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
BJU International|August 29, 2015
Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (HIV)-positive population: experience in an Australian major HIV centreWee Loon Ong, Paul Manohar, Jeremy Millar, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in AustraliaWee Loon Ong, Melanie Evans, Nathan Papa, et al.
Journal of Medical Imaging and Radiation Oncology|October 9, 2018
Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry VictoriaWee Loon Ong, Farshad Foroudi, Sue Evans, et al.
Pageof 11